InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-29.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Kennedy Thomas Ronan, 首席执行官. Insider active across 1 company, notably cbdMD, Inc.. Aggregated, 5 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €22k. History available since 24 August 2021. The latest transaction was filed on 3 May 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kennedy Thomas Ronan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
445,000 股Common StockSEC:0001437749-25-036688:0
67,869 股Common StockSEC:0001437749-25-015501:0
5,000 股@ US$2.1027.0% 占其流量Common StockSEC:0001437749-23-012787:0
标准退出：2023年8月1日 (T+90)
16,667 股Common StockSEC:0001654954-21-010812:0
7,400 股@ US$2.0457.5% 占其流量Common stockSEC:0001654954-21-009413:0
标准退出：2021年11月22日 (T+90)
5 条申报中的 5 条
About Kennedy Thomas Ronan
Thomas Ronan Kennedy is the CEO and CFO of cbdMD, Inc. He is responsible for the strategic and financial leadership of the company, ensuring it meets its growth and profitability objectives.
